Abstract
Our aim was to examine correlations between polymorphisms in five antioxidant enzymes genes, activity of free-radical processes, and the risk of restenosis after coronary artery stenting with bare metal stents (BMS). A total of 101 male patients who underwent intracoronary stenting using BMS and coronary angiography follow-up of 6 months were enrolled in: group with in-stent restenosis (n = 44) and without restenosis (n = 57). The content of lipoperoxides and malondialdehyde (MDA) in Low-density lipoprotein (LDL), activity of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) in erythrocytes, and genotypes polymorphisms of the CAT gene (−262C/T), paraoxonase-1 (PON-1) gene (163T/A and 575A/G), endothelial nitric oxide synthase (eNOS) gene (298G/T (rs#1799983) and −786T/C), GPx-1 gene (599C/T (rs#1050450)), and glutathione-S-transferase (GSTP) gene (313A/G) were determined. In carriers of the minor allele of 599C/T polymorphism of the GPx-1 gene, activity of GPx in erythrocytes was lower by 17 % than in wild allele homozygotes, while the content of lipoperoxides in LDL was higher by 74 %. T-allele of 599C/T polymorphism of the GPx-1 gene (OR = 2.9; 95 % CI: 1.23–6.82) and T-allele of 298G/T polymorphism of the eNOS gene (OR = 2.79; 95 % CI: 1.17–6.66) were associated with the risk of in-stent restenosis. Minor alleles of polymorphisms 298G/T of the eNOS gene and 599C/T of the GPx-1 gene are associated with an increased risk of in-stent restenosis. Minor allele of the GPx-1 gene 599C/T polymorphism leads to a decrease of the GPx activity and increase of the activity of free-radical processes.
Similar content being viewed by others
References
Spertus JA, Nerella R, Kettlekamp R, House J, Marso S, Borkon MA, Rumsfeld JS (2005) Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery. Circulation 111:768–773. doi:10.1161/01.CIR.0000155242.70417.60
Kastrati A, Koch W, Gawaz M, Mehilli J, Böttiger C, Schömig K, von Beckerath N, Schömig A (2000) PLA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol 36:84–89
Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann F-J, von Beckerath N, Böttiger C, Duff GW, Schömig A (2000) Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 36:2168–2173
Wijpkema JS, Van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA (2006) Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or hemeoxygenase-1. Pharmacogenet Genomics 16:331–337
Galluccio E, Piatti PM, Citterio L, Lucotti PCG, Setola E, Cassina L, Oldani M, Zavaroni I, Bosi E, Colombo A, Alfieri O, Casari G, Reaven GM, Monti LD (2008) Hyperinsulinemia and impaired leptin: adiponectin ratio associate with endothelial nitric oxide synthase polymorphisms in patients with in-stent restenosis. Am J Physiol Endocrinol Metab 294:E978–E986. doi:10.1152/ajpendo.00003.2008
Azevedo LC, Pedro MA, Souza LC, de Souza HP, Janiszewski M, da Luz PL, Laurindo FRM (2000) Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc Res 47:436–445. doi:10.1016/S0008-6363(00)00091-2
Hoffmann R, Mintz GS (2000) Coronary in-stent restenosis—predictors, treatment and prevention. Eur Heart J 21:1739–1749. doi:10.1053/euhj.2000.2153
Iuliano L, Colavita AR, Leo R, Pratico D, Violi F (1997) Oxygen free radicals and platelet activation. Free Radic Biol Med 22:999–1006
Fortuno A, San Jose G, Moreno MU, Díez J, Zalba G (2005) Oxidative stress and vascular remodelling. Exp Physiol 90:457–462. doi:10.1113/expphysiol.2005.030098
Zhou XF, Cui J, De Stefano Al, Chazaro I, Farrer LA, Manolis AJ, Gavras H, Baldwin CT (2005) Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 21:3–7
Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan M-L, Allayee H, Lusis AJ, Hazen SL (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 299:1265–1276. doi:10.1001/jama.299.11.1265
Van Himbergen TM, Roest M, Graaf J, Jansen EHJM, Hattori H, Kastelein JJP, Voorbij HAM, Stalenhoef AFH, van Tits LJH (2005) Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia. J Lipid Res 46:445–451. doi:10.1194/jlr.M400052-JLR200
Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389–395. doi:10.1373/49.3.389
Schnabel R, Lackner KJ, Rupprecht HJ, Espinola-Klein C, Torzewski M, Lubos E, Bickel C, Cambien F, Tiret L, Münzel T, Blankenberg S (2005) Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction. J Am Coll Cardiol 45:1631–1637. doi:10.1016/j.jacc.2005.02.053
Nemoto M, Nishimura R, Sasaki T, Hiki Y, Miyashita Y, Nishioka M, Fujimoto K, Sakuma T, Ohashi T, Fukuda K, Eto Y, Tajima N (2007) Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol 6:23–27
Amplatz K, Formanek G, Stranger P, Wilson W (1967) Mechanics of selective coronary artery catheterization via femoral approach. Radiology 89:1040–1047. doi:10.1148/89.6.1040
Judkins MP (1967) Selective coronary arteriography. Part I. A percutaneous transfemoral technic. Radiology 89:815–824. doi:10.1148/89.5.815
Tertov VV, Kaplun VV, Dvoryantsev SN, Orekhov AN (1995) Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo. Biochem Biophys Res Commun 214:608–613
Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, Tikhaze AK, Ageev AK, Kukharchuk VV, Belenkov YN (2005) Oxidative stress in atherosclerosis and diabetes. Bull Exp Biol Med 140:41–43
Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403–409
Boldyrev AA, Yuneva MO, Sorokina EV, Kramarenko GG, Fedorova TN, Konovalova GG, Lankin VZ (2001) Antioxidant systems in tissues of senescence accelerated mice. Biochemistry (Mosc) 66:1157–1163
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289–300
Lowe HC, Oesterle SN, Khachigian LM (2002) Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 39:183–193
Inouye M, Mio T, Sumino K (1999) Link between glycation and lipooxidation in red blood cells in diabetes. Clin Chim Acta 285:35–44
Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexø BA, Wallin H, Overvad K, Raaschou-Nielsen O, Vogel U (2006) Association between GPx-1 Pro198Leu polymorphism, erythrocyte GPx activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27:820–825. doi:10.1093/carcin/bgi267
Hamanishi T, Fyryta H, Kato H, Doi A, Tamai M, Shimomura H, Sakagashira S, Nishi M, Sasaki H, Sanke T, Nanjo K (2004) Functional variants in the glutathione peroxidase-1 (GPx-1) gene are associated with increased intimamedia thickness of carotid arteries and risk of macrovascular disease in Japanese type 2 diabetic patients. Diabetes 53:2455–2460. doi:10.2337/diabetes.53.9.2455
Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and ugly. Am J Physiol 5:1424–1437
Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ, AtheroGene Investigators (2003) Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 349:1605–1613
Suzuki T, Okumura K, Sone T, Kosokabe T, Tsuboi H, Kondo J, Mukawa H, Kamiya H, Tomida T, Imai H, Matsui H, Hayakawa T (2002) The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis. Int J Cardiol 86:71–76
Gomma AH, Elrayess MA, Knight CJ, Hawe E, Fox KM, Humphries SE (2002) The endothelial nitric oxide synthase (Glu298Asp and −786T>C) gene polymorphism are associated with coronary in-stent restenosis. Eur Heart J 23:1955–1962. doi:10.1053/euhj.2002.3400
Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774–1777. doi:10.1172/JCI114081
Griendling KK, Fitzgerald GF (2003) Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108:1912–1916. doi:10.1161/01.CIR.0000093660.86242.BB
Jain SK, Palmer M (1997) The effects of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 22:593–596
Tesauro M, Tompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary disease: cleavage of proteins with aspartate vs. glutamate at position 298. PNAS 97:2832–2835. doi:10.1073/pnas.97.6.2832
Khalkhai-Ellis Z, Hendrix MJ (2003) Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. Am J Pathol 162:1411–1417
Acknowledgments
This work was supported by a grant of Russian Foundation for Basic Research (06-04-49691-a). We thank Dr. Vadim Z. Lankin and Dr. Alla K. Tikhaze for their support of some biochemistry research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shuvalova, Y.A., Kaminnyi, A.I., Meshkov, A.N. et al. Association between polymorphisms of eNOS and GPx-1 genes, activity of free-radical processes and in-stent restenosis. Mol Cell Biochem 370, 241–249 (2012). https://doi.org/10.1007/s11010-012-1419-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-012-1419-3